Key result
Adenylyl cyclase 1 inhibition cuts phenylephrine-induced rate change by ~43% in mouse atrial tissue.
Why the study?
The IP3 signalling pathway has been proposed as an atrial-specific AF target linked to calcium-sensitive AC1 and AC8, motivating investigation into AC1 involvement in atrial pacemaker responses.
Does the selective AC1 inhibitor ST034307 reduce phenylephrine-induced changes in sino-atrial node beat rate in mouse and guinea pig models?
Does the selective AC1 inhibitor ST034307 reduce phenylephrine-induced changes in sino-atrial node beat rate in mouse and guinea pig models?
Absolute Event Rate: 8.2% vs 14.5%
p-value: p=0.005
Pharmacological inhibition of AC1 by ST034307 reduces the positive chronotropic effect of alpha-adrenergic stimulation in the sino-atrial node, highlighting the role of AC1 in atrial pacemaker activity.
Does not support clinical use of AC1 inhibition; hypothesis-generating for its role in sinoatrial node alpha-adrenergic responses.
Atrial arrhythmias, such as atrial fibrillation (AF), are a major mortality risk and a leading cause of stroke. The IP 3 signalling pathway has been proposed as an atrial-specific target for AF therapy, and atrial IP 3 signalling has been linked to the activation of calcium sensitive adenylyl cyclases AC1 and AC8. We investigated the involvement of AC1 in the response of intact mouse atrial tissue and isolated guinea pig atrial and sino-atrial node (SAN) cells to the α-adrenoceptor agonist phenylephrine (PE) using the selective AC1 inhibitor ST034307. The maximum rate change of spontaneously beating mouse right atrial tissue exposed to PE was reduced from 14.5% to 8.2% ( p = 0.005) in the presence of 1 μM ST034307, whereas the increase in tension generated in paced left atrial tissue in the presence of PE was not inhibited by ST034307 (Control = 14.2%, ST034307 = 16.3%; p > 0.05). Experiments were performed using isolated guinea pig atrial and SAN cells loaded with Fluo-5F-AM to record changes in calcium transients (CaT) generated by 10 μM PE in the presence and absence of 1 μM ST034307. ST034307 significantly reduced the beating rate of SAN cells (0.34-fold decrease; p = 0.003) but did not inhibit changes in CaT amplitude in response to PE in atrial cells. The results presented here demonstrate pharmacologically the involvement of AC1 in the downstream response of atrial pacemaker activity to α-adrenoreceptor stimulation and IP 3 R calcium release.
No takes yet. Share an insight, caveat, or question.
Bose et al. (2022) studied Healthy animal models (Guinea pig and mouse). ST034307 vs. Control (absence of ST034307) was evaluated on Maximum rate change of spontaneously beating mouse right atrial tissue exposed to phenylephrine (p=0.005). Inhibition of adenylyl cyclase 1 by 1 μM ST034307 significantly reduced the maximum rate change of spontaneously beating mouse right atrial tissue exposed to phenylephrine from 14.5% to 8.2%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: